Last update 13 Feb 2025

MVF-HER-2 (266-296) Vaccine(Indiana University)

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsDigestive System DisordersSkin and Musculoskeletal Diseases
Active Indication
Advanced Malignant Solid NeoplasmHER2 Positive Breast CancerHER2-positive gastric cancer+ [2]
Inactive Indication-
Originator Organization
Indiana UniversityIndiana University
Active Organization
Indiana UniversityIndiana University
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MVF-HER-2 (266-296) Vaccine(Indiana University)
NCT06414733
/ RecruitingPhase 1IIT
Phase Ib Active Immunotherapy Trial (Expansion) With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B Cell Peptide Vaccine Emulsified in ISA 720 Adjuvant in Patients With Advanced Solid Tumors
100 Clinical Results associated with MVF-HER-2 (266-296) Vaccine(Indiana University)
Login to view more data
100 Translational Medicine associated with MVF-HER-2 (266-296) Vaccine(Indiana University)
Login to view more data
100 Patents (Medical) associated with MVF-HER-2 (266-296) Vaccine(Indiana University)
Login to view more data
100 Deals associated with MVF-HER-2 (266-296) Vaccine(Indiana University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
US
Indiana UniversityIndiana University
12 Jan 2025
HER2 Positive Breast CancerPhase 1
US
Indiana UniversityIndiana University
12 Jan 2025
HER2-positive gastric cancerPhase 1
US
Indiana UniversityIndiana University
12 Jan 2025
Metastatic breast cancerPhase 1
US
Indiana UniversityIndiana University
12 Jan 2025
Metastatic Digestive System CarcinomaPhase 1
US
Indiana UniversityIndiana University
12 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free